×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study
KLAS 8 News Now
Data demonstrates a 7-day treatment regimen with the pan-coronavirus protease inhibitor ALG-097558 was well tolerated and does not require...
3 days ago
Aligos Therapeutics, Inc. (ALGS) Just Flashed Golden Cross Signal: Do You Buy?
Yahoo Finance
Aligos Therapeutics, Inc. (ALGS) Just Flashed Golden Cross Signal: Do You Buy? ... In this article: ALGS. After reaching an important support...
1 month ago
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Sees Large Decrease in Short Interest
MarketBeat
Aligos Therapeutics, Inc. (NASDAQ:ALGS - Get Free Report) saw a significant decrease in short interest in April. As of April 15th,...
2 days ago
Aligos Therapeutics describes new prodrugs to treat hepatitis B and D virus infections
BioWorld MedTech
Aligos Therapeutics Inc. has identified prodrugs reported to be useful for the treatment of hepatitis B and hepatitis D viral infections.
1 week ago
Aligos Therapeutics, Inc. (NASDAQ:ALGS) Stock Catapults 27% Though Its Price And Business Still Lag The Industry
Simply Wall Street
Despite an already strong run, Aligos Therapeutics, Inc. ( NASDAQ:ALGS ) shares have been powering on, with a gain of...
3 weeks ago
Aligos reports positive Phase 1 data for coronavirus drug
Investing.com
SOUTH SAN FRANCISCO - Aligos Therapeutics, Inc. (NASDAQ:ALGS), a biopharmaceutical company, announced positive Phase 1 results for its...
3 days ago
Aligos Therapeutics on the Brink: The Urgent Race to Maintain Nasdaq Listing and Avoid Delisting Consequences ...
Tipranks
Aligos Therapeutics, Inc. (ALGS) has disclosed a new risk, in the Share Price & Shareholder Rights category. Aligos Therapeutics, Inc. faces...
1 month ago
Is Aligos Therapeutics (ALGS) Stock Outpacing Its Medical Peers This Year?
Yahoo Finance
Here is how Aligos Therapeutics, Inc. (ALGS) and Allogene Therapeutics (ALLO) have performed compared to their sector so far this year.
3 months ago
Liver specialist Aligos scores $92m in private placement funding
Pharmaceutical Technology
As it builds momentum towards a Phase IIa study for its NASH drug, Aligos aims to be a THR-β agonist market contender.
6 months ago
Aligos Therapeutics Launches Stock Option Exchange Program - TipRanks.com
Tipranks
The latest update is out from Aligos Therapeutics (ALGS). Aligos Therapeutics, Inc. initiated a stock option exchange program allowing employees and...
2 months ago